Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
13.26
-1.15 (-7.98%)
At close: Dec 5, 2025, 4:00 PM EST
13.26
0.00 (-0.02%)
After-hours: Dec 5, 2025, 5:39 PM EST

Company Description

Carlsmed, Inc., a commercial-stage company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions.

The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures.

Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants.

The company was incorporated in 2018 and is based in Carlsbad, California.

Carlsmed, Inc.
Carlsmed logo
Country United States
Founded 2018
IPO Date Jul 23, 2025
Industry Health Information Services
Sector Healthcare
Employees 89
CEO Michael Cordonnier

Contact Details

Address:
1800 Aston Avenue, Suite 100
Carlsbad, California 92008
United States
Phone 760 766 1923
Website carlsmed.com

Stock Details

Ticker Symbol CARL
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $15.00
CIK Code 0001794546
CUSIP Number 14280C105
ISIN Number US14280C1053
Employer ID 83-1081863
SIC Code 3841

Key Executives

Name Position
Michael John Cordonnier Co-Founder, Chairman, Chief Executive Officer and President
Leonard M. Greenstein J.D. Chief Financial Officer and Treasurer
William Durall Chief Commercial Officer
Niall Patrick Casey J.D. Co-Founder, Chief Intellectual Property Officer and Director
Shariq Hussain Chief Technology Officer
Jenifer Kamocsay Chief Legal Officer and Secretary
Jodi Allen Coe M.B.A. Senior Vice President of People and Culture
Sharon V. Schulzki Chief Clinical and Market Access Officer
Jeff Bertolini Senior Vice President of Operational Excellence

Latest SEC Filings

Date Type Title
Nov 14, 2025 SCHEDULE 13G Filing
Nov 13, 2025 SCHEDULE 13G Filing
Nov 6, 2025 10-Q Quarterly Report
Nov 6, 2025 8-K Current Report
Oct 30, 2025 8-K Current Report
Aug 28, 2025 10-Q Quarterly Report
Aug 28, 2025 8-K Current Report
Jul 24, 2025 SCHEDULE 13G Filing
Jul 24, 2025 8-K Current Report
Jul 24, 2025 S-8 Securities to be offered to employees in employee benefit plans